| Date Filed | Type | Description |
| 06/15/2023 |
4
| White William Richard (CFO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 606 shares
@ $55.16, valued at
$33.4k
|
|
| 06/12/2023 |
4
| White William Richard (Director) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Granted 15,937 options to buy
@ $34.83, valued at
$555.1k
|
|
| 06/09/2023 |
4
| White William Richard (Director) has filed a Form 4 on Disc Medicine, Inc.|
Txns:
| Granted 7,136 options to buy
@ $45.69, valued at
$326k
|
|
| 04/26/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 03/14/2023 |
4
| White William Richard (CFO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 641 shares
@ $43.47, valued at
$27.9k
|
|
| 01/24/2023 |
4
| White William Richard (Director) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Sold 5,048 shares
@ $34.3258, valued at
$173.3k
Sold 21,278 shares
@ $35.0117, valued at
$745k
Sold 7,027 shares
@ $35.9095, valued at
$252.3k
Exercised 33,353 options to buy
@ $6.03, valued at
$201.1k
|
|
| 01/03/2023 |
4
| White William Richard (Director) has filed a Form 4 on Disc Medicine, Inc.|
Txns:
| Granted 7,000 options to buy
@ $13.5, valued at
$94.5k
|
|
| 01/03/2023 |
3
| White William Richard (Director) has filed a Form 3 on Disc Medicine, Inc. |
| 12/29/2022 |
4
| White William Richard (CFO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 19,001 shares
@ $49.7663, valued at
$945.6k
Sold 999 shares
@ $49.7635, valued at
$49.7k
Exercised 19,001 options to buy
@ $7.009, valued at
$133.2k
Exercised 999 options to buy
@ $7.009, valued at
$7k
|
|
| 12/20/2022 |
4
| White William Richard (CFO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Granted 29,073 options to buy
@ $21.1, valued at
$613.4k
|
|
| 12/13/2022 |
4
| White William Richard (CFO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Granted 19,195 shares
@ $0
Granted 86,379 options to buy
@ $42.95, valued at
$3.7M
|
|
| 10/17/2022 |
4
| White William Richard (CFO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 20,000 shares
@ $39.82, valued at
$796.4k
Exercised 20,000 options to buy
@ $7.009, valued at
$140.2k
|
|
| 09/15/2022 |
4
| White William Richard (CFO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 18,920 shares
@ $26.42, valued at
$499.9k
Sold 13,580 shares
@ $27.87, valued at
$378.5k
Exercised 32,500 options to buy
@ $7.009, valued at
$227.8k
|
|
| 09/13/2022 |
4
| White William Richard (CFO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Granted 1,152 shares
@ $8.03, valued at
$9.3k
Granted 29,074 options to buy
@ $21.1, valued at
$613.5k
Granted 29,074 options to buy
@ $21.1, valued at
$613.5k
|
|
| 06/10/2022 |
4
| White William Richard (Director) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Granted 13,301 options to buy
@ $16.54, valued at
$220k
|
|
| 01/18/2022 |
4
| White William Richard (CFO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 9,700 shares
@ $22.03, valued at
$213.7k
Exercised 9,700 options to buy
@ $7.009, valued at
$68k
|
|
| 12/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/03/2021 |
4
| White William Richard (CFO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Sold 6,500 shares
@ $22.24, valued at
$144.6k
Exercised 6,500 options to buy
@ $7.009, valued at
$45.6k
|
|
| 10/20/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/09/2020 |
4
| White William Richard (CFO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Granted 1,245 shares
@ $17.068, valued at
$21.2k
Granted 77,580 options to buy
@ $28.35, valued at
$2.2M
|
|
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2019 |
4
| White William Richard (CFO) has filed a Form 4 on Akero Therapeutics, Inc.|
Txns:
| Granted 85,000 options to buy
@ $21.09, valued at
$1.8M
|
|
| 06/19/2019 |
3
| White William Richard (EVP, CFO) has filed a Form 3 on Akero Therapeutics, Inc. |